Samrat Pharmachem Live Share Price Today, Share Analysis and Chart

Name: Samrat Pharmachem Ltd.: Is Infosys Ltd. worth buying?
Item: Samrat Pharmachem Ltd.
Rating: 2.089291625
Author: Trendlyne DVM scores

Expensive Underperformer

Iran war impact

Based on the company's financial disclosures for FY2025 and the first nine months of FY2026, the impact of the Middle East conflict on Samrat Pharmachem Ltd. is assessed as Negative to Minimal, primarily driven by indirect supply chain pressu...

206.45 8.55 (4.32%)

New 52W Low in past week

1,795

BSE Volume

BSE 02 Apr, 2026 3:31 PM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

Medium Financial Strength

- / 100

Expensive Valuation

- / 100

Technically Bearish

29.3 / 100

Expensive Underperformer These stocks have average quality, expensive valuations and weak momentum. Investors should exercise caution View Similar Embed DVM

No estimates available

Samrat Pharmachem Live Price Chart

Loading Fundamental data..

Loading data..

Is Samrat Pharmachem Ltd. worth buying?

48 Votes:

Buy 68.75%

Sell 12.5%

Hold 18.75%

Samrat Pharmachem Live Share Price Today, Share Analysis and Chart

Based on the company's financial disclosures for FY2025 and the first nine months of FY2026, the impact of the Middle East conflict on Samrat Pharmachem Ltd. is assessed as Negative to Minimal, primarily driven by indirect supply chain pressu...

New 52W Low in past week

SWOT Analysis

Samrat Pharmachem Live Price Chart